EZH2 and gastric cancer: A previous study showed that SNHG17 was located in the nucleus and could suppress P57 expression by binding with enhancer of zester homolog 2 (EZH2) in colorectal cancer (Ma et al., 2017) and gastric cancer (Zhang G et al., 2019).